scispace - formally typeset
C

Christopher B. Newgard

Researcher at Duke University

Publications -  483
Citations -  55811

Christopher B. Newgard is an academic researcher from Duke University. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 111, co-authored 460 publications receiving 49018 citations. Previous affiliations of Christopher B. Newgard include Durham University & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Effects of microbiota-directed foods in gnotobiotic animals and undernourished children

TL;DR: Identifying ingredients in complementary foods, consumed during the transition from exclusive milk feeding to a fully weaned state, that increase the representation and expressed beneficial functions of growth-promoting bacterial taxa in the developing microbiota could provide an effective, affordable, culturally acceptable, and sustainable approach to treatment.
Journal ArticleDOI

Metabolic cycling in control of glucose-stimulated insulin secretion

TL;DR: A case is built for the particular relevance of byproducts of the pyruvate/isocitrate cycle, NADPH and alpha-ketoglutarate, in control of GSIS.
Journal ArticleDOI

Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease

TL;DR: It is concluded that CAR activation improves type 2 diabetes, and that these actions of CAR suggest therapeutic approaches to the disease.
Journal ArticleDOI

The Gut Microbiota Modulates Energy Metabolism in the Hibernating Brown Bear Ursus arctos

TL;DR: Transplantation of the bear microbiota from summer and winter to germ-free mice transferred some of the seasonal metabolic features and demonstrated that the summer microbiota promoted adiposity without impairing glucose tolerance, suggesting that seasonal variation in the microbiota may contribute to host energy metabolism in the hibernating brown bear.
Journal ArticleDOI

PGC-1β in the Regulation of Hepatic Glucose and Energy Metabolism

TL;DR: The reduced ability of PGC-1β to induce gluconeogenic genes is due, at least in part, to its inability to physically associate with and coactivate hepatic nuclear receptor 4α (HNF4α) and forkhead transcription factor O1 (FOXO1), two critical transcription factors that mediate the activation of gluc oneogenic gene expression by P GC-1α.